药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cysteamine
Lidoflazine
The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Clomipramine.
Cysteamine
Bencyclane
The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Clomipramine.
Cysteamine
Gallopamil
The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Clomipramine.
Cysteamine
Aranidipine
The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Clomipramine.
Cysteamine
Pinaverium
The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Clomipramine.
Cysteamine
Niguldipine
The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Niguldipine.
Cysteamine
Piromidic acid
The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Clomipramine.
Cysteamine
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Clomipramine.
Cysteamine
Lorajmine
The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Clomipramine.
Cysteamine
Prajmaline
The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Clomipramine.
Cysteamine
Cibenzoline
The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Clomipramine.
Cysteamine
Cicletanine
The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Clomipramine.
Cysteamine
Pilsicainide
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Clomipramine.
Cysteamine
Givinostat
The risk or severity of QTc prolongation can be increased when Givinostat is combined with Clomipramine.
Cysteamine
Temefos
The risk or severity of QTc prolongation can be increased when Temefos is combined with Clomipramine.
Cysteamine
CUDC-907
The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Clomipramine.
Cysteamine
Bilastine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Clomipramine.
Cysteamine
Phosmet
The risk or severity of QTc prolongation can be increased when Phosmet is combined with Clomipramine.
Cysteamine
Fenthion
The risk or severity of QTc prolongation can be increased when Fenthion is combined with Clomipramine.
Cysteamine
Famphur
The risk or severity of QTc prolongation can be increased when Famphur is combined with Clomipramine.